Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Trial of CCI-779 in Patients With Soft Tissue Sarcoma.

Trial Profile

A Trial of CCI-779 in Patients With Soft Tissue Sarcoma.

Phase of Trial: Phase II

Latest Information Update: 03 Jun 2013

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Gastrointestinal stromal tumours; Soft tissue sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 02 Jan 2013 Actual end date changed from Jun 2010 to Dec 2005 as reported by ClinicalTrials.gov.
    • 05 May 2011 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top